Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Takasu, Hideki; Fujita, Shigekazu; Ohtsuka, Shinya; Hirose, Toshiyuki; Sato, Yosuke; Yamada, Satoshi; Miyajima, Keisuke; Sakai, Koji; Kojima, Yutaka; Sekiguchi, Kazuo; Yanagihara, Yasuo; Suzuki, Takashi; Tanaka, Hideo; Sugiyama, Kazuhisa; Okuno, Mitsuhiro; Sumida, Takumi

Agent Davies Collison Cave

Pub. Number AU-A-2011211306

PCT Pub. Number WO2011/093524

Priority 61/359,729 29.06.10 US; 61/299,631 29.01.10 US

Filing date 28 January 2011

Wipo publication date 4 August 2011

C07D 213/69 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 - Non-condensed pyridines

A61K 31/443

A61K 31/4439

A61K 31/4545

A61K 31/4725

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 Antineoplastic agents

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group